S1PR1 and hepatocellular carcinoma: In vitro and in vivo, high expression of S1PR1 in endothelial cells (ECs) promotes angiogenesis and HCC progression, suggesting that S1PR1 may be an important target for suppressing angiogenesis in HCC and that inhibiting S1PR1 may represent a promising approach toward HCC treatment [69].